Prospective evaluation of a novel silicone corneal shield after PRK: 6-month efficacy, safety, and predictability outcomes

Christopher S Sáles,1 Edward E Manche2 1Weill Cornell Medical College, Department of Ophthalmology, New York, NY, USA; 2Byers Eye Institute, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA, USA Purpose: The aim of this study was to report the 1-week an...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sáles CS, Manche EE
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	PRK Contact Lens Safety Wound healing Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/786375890f9348b7a503557f79705427
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:786375890f9348b7a503557f79705427
record_format	dspace
spelling	oai:doaj.org-article:786375890f9348b7a503557f797054272021-12-02T03:10:16ZProspective evaluation of a novel silicone corneal shield after PRK: 6-month efficacy, safety, and predictability outcomes1177-5483https://doaj.org/article/786375890f9348b7a503557f797054272019-01-01T00:00:00Zhttps://www.dovepress.com/prospective-evaluation-of-a-novel-silicone-corneal-shield-after-prk-6--peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Christopher S Sáles,1 Edward E Manche2 1Weill Cornell Medical College, Department of Ophthalmology, New York, NY, USA; 2Byers Eye Institute, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA, USA Purpose: The aim of this study was to report the 1-week and 6-month refractive outcomes of eyes treated with a novel silicone corneal shield designed to improve visual recovery after photorefractive keratectomy (PRK).Patients and methods: This prospective, observational clinical trial recruited 45 myopic eyes with or without astigmatism at a university eye clinic to undergo wavefront-guided PRK followed by application of an investigational silicone corneal shield that was removed on postoperative day 4. The primary outcome measures were efficacy, predictability, and safety at the 6-month visit. The secondary end points included short-term uncorrected distance visual acuity (UDVA) and pain.Results: No adverse outcomes occurred using the device. At 6 months, 79.5% of eyes achieved UDVA >20/20, 94.9% achieved ≥20/25, and 97.4% achieved ≥20/40. Also, 2.6% lost one line of corrected distance visual acuity and none lost two lines; 71.8% and 97.4% measured within ±0.25 and ±0.50 D of emmetropia, respectively. During the first week, preoperative UDVA improved from 1.34 logarithm of the minimum angle of resolution (logMAR; <20/400 Snellen) to 0.14 logMAR (>20/30) on postoperative day 1 (P<0.0001) and remained stable on days 2–3 (all P>0.05). After removal of the shield on day 4, UDVA declined by two lines before rebounding to 0.16 logMAR (>20/30) on day 7 (both P<0.001). Subjective metrics of pain all peaked between days 2 and 3 before declining.Conclusion: The investigational silicone corneal shield is safe and effective when used after PRK and may aid early visual recovery and patient comfort, but comparative studies are needed to validate these preliminary findings.Precis: One-week and 6-month refractive outcomes of a novel silicone corneal shield used after PRK show that the device is not only safe and effective but may also speed visual recovery. Keywords: PRK, contact lens, safety, wound healingSáles CSManche EEDove Medical PressarticlePRKContact LensSafetyWound healingOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 13, Pp 115-121 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	PRK Contact Lens Safety Wound healing Ophthalmology RE1-994
spellingShingle	PRK Contact Lens Safety Wound healing Ophthalmology RE1-994 Sáles CS Manche EE Prospective evaluation of a novel silicone corneal shield after PRK: 6-month efficacy, safety, and predictability outcomes
description	Christopher S Sáles,1 Edward E Manche2 1Weill Cornell Medical College, Department of Ophthalmology, New York, NY, USA; 2Byers Eye Institute, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA, USA Purpose: The aim of this study was to report the 1-week and 6-month refractive outcomes of eyes treated with a novel silicone corneal shield designed to improve visual recovery after photorefractive keratectomy (PRK).Patients and methods: This prospective, observational clinical trial recruited 45 myopic eyes with or without astigmatism at a university eye clinic to undergo wavefront-guided PRK followed by application of an investigational silicone corneal shield that was removed on postoperative day 4. The primary outcome measures were efficacy, predictability, and safety at the 6-month visit. The secondary end points included short-term uncorrected distance visual acuity (UDVA) and pain.Results: No adverse outcomes occurred using the device. At 6 months, 79.5% of eyes achieved UDVA >20/20, 94.9% achieved ≥20/25, and 97.4% achieved ≥20/40. Also, 2.6% lost one line of corrected distance visual acuity and none lost two lines; 71.8% and 97.4% measured within ±0.25 and ±0.50 D of emmetropia, respectively. During the first week, preoperative UDVA improved from 1.34 logarithm of the minimum angle of resolution (logMAR; <20/400 Snellen) to 0.14 logMAR (>20/30) on postoperative day 1 (P<0.0001) and remained stable on days 2–3 (all P>0.05). After removal of the shield on day 4, UDVA declined by two lines before rebounding to 0.16 logMAR (>20/30) on day 7 (both P<0.001). Subjective metrics of pain all peaked between days 2 and 3 before declining.Conclusion: The investigational silicone corneal shield is safe and effective when used after PRK and may aid early visual recovery and patient comfort, but comparative studies are needed to validate these preliminary findings.Precis: One-week and 6-month refractive outcomes of a novel silicone corneal shield used after PRK show that the device is not only safe and effective but may also speed visual recovery. Keywords: PRK, contact lens, safety, wound healing
format	article
author	Sáles CS Manche EE
author_facet	Sáles CS Manche EE
author_sort	Sáles CS
title	Prospective evaluation of a novel silicone corneal shield after PRK: 6-month efficacy, safety, and predictability outcomes
title_short	Prospective evaluation of a novel silicone corneal shield after PRK: 6-month efficacy, safety, and predictability outcomes
title_full	Prospective evaluation of a novel silicone corneal shield after PRK: 6-month efficacy, safety, and predictability outcomes
title_fullStr	Prospective evaluation of a novel silicone corneal shield after PRK: 6-month efficacy, safety, and predictability outcomes
title_full_unstemmed	Prospective evaluation of a novel silicone corneal shield after PRK: 6-month efficacy, safety, and predictability outcomes
title_sort	prospective evaluation of a novel silicone corneal shield after prk: 6-month efficacy, safety, and predictability outcomes
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/786375890f9348b7a503557f79705427
work_keys_str_mv	AT salescs prospectiveevaluationofanovelsiliconecornealshieldafterprk6monthefficacysafetyandpredictabilityoutcomes AT mancheee prospectiveevaluationofanovelsiliconecornealshieldafterprk6monthefficacysafetyandpredictabilityoutcomes
_version_	1718401925971443712

Prospective evaluation of a novel silicone corneal shield after PRK: 6-month efficacy, safety, and predictability outcomes

Ejemplares similares